Related Experiment Videos
PHEMA as a fibrous capsule-resistant breast prosthesis
1Department of Anesthesia and Critical Care, Massachusetts General Hospital, Boston 02114-2696, USA. fvacanti@partners.org
Plastic and Reconstructive Surgery
|April 28, 2004
Summary
Poly-2-hydroxyethyl methacrylate (PHEMA) implants show reduced fibrous encapsulation compared to silicone implants in early-stage breast reconstruction. This finding suggests PHEMA may offer improved long-term cosmetic results for prosthetic implants.
Area of Science:
- Biomaterials Science
- Plastic Surgery Research
- Tissue Engineering
Background:
- Silicone (poly-dimethyl siloxane) breast prostheses commonly cause fibrous capsular contracture, deforming the implant.
- This encapsulation negatively impacts the long-term cosmetic outcomes of breast reconstruction.
- Developing novel implant materials with reduced foreign body response is crucial.
Purpose of the Study:
- To compare the early fibrous encapsulation response of poly-2-hydroxyethyl methacrylate (PHEMA) against silicone.
- To evaluate the potential of PHEMA as an alternative material for prosthetic implants.
Main Methods:
- Subcutaneous implantation of poly-dimethyl siloxane (control) and PHEMA disks in five rats.
- Assessment of fibrous tissue encapsulation at six weeks post-implantation.
Main Results:
- Poly-dimethyl siloxane implants exhibited significant fibrous tissue encapsulation.
- PHEMA implants showed no apparent fibrous tissue surrounding them at six weeks.
- PHEMA demonstrated statistically superior results in reducing fibrous encapsulation compared to silicone (p = 0.0312).
Conclusions:
- PHEMA exhibits a diminished tendency for fibrous encapsulation compared to silicone in early-stage implantation.
- These findings suggest PHEMA holds promise for improving long-term outcomes in prosthetic breast implants.
- Further research into PHEMA's biocompatibility and efficacy is warranted.